ClinConnect ClinConnect Logo
Search / Trial NCT01867684

Positive PsychoTherapy in Acquired Brain Injury (ABI) Rehabilitation

Launched by NHS GREATER GLASGOW AND CLYDE · Jun 3, 2013

Trial Information

Current as of September 10, 2025

Completed

Keywords

Stroke Acquired Brain Injury

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 18 years or over;
  • Diagnosis of stroke or acquired brain injury (confirmed clinically and/or radiologically);
  • Between 3 and 12 months post-injury at time of recruitment;
  • Presence of emotional distress (score in moderate or above range on at least one sub-scale of the Depression Anxiety Stress Scales; DASS-21);
  • Medically stable;
  • Able to consent to research.
  • Exclusion Criteria:
  • Significant communication impairments that would preclude participation;
  • Diagnosis of mild traumatic brain injury (due to the known additional complexities contributing to outcome in this population);
  • Comorbid developmental learning disability or degenerative neurological condition.
  • Pre-injury history of mood disorder will not lead to exclusion.

About Nhs Greater Glasgow And Clyde

NHS Greater Glasgow and Clyde (NHS GG&C) is one of the largest health organizations in the UK, dedicated to delivering high-quality healthcare services to a diverse population. As a clinical trial sponsor, NHS GG&C plays a pivotal role in advancing medical research and improving patient outcomes through innovative clinical studies. The organization is committed to upholding rigorous ethical standards and regulatory compliance, ensuring that all trials are conducted with the utmost care for participant safety and scientific integrity. With a focus on collaboration, NHS GG&C partners with academic institutions, healthcare professionals, and industry stakeholders to foster an environment conducive to groundbreaking research and the development of new therapies.

Locations

Glasgow, United Kingdom

Patients applied

0 patients applied

Trial Officials

Jonathan Evans, PhD

Principal Investigator

University of Glasgow

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials